Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy
Title:
Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy
Author:
Qiao, Guoliang Ilagan, Crisanta H. Fernandez-del Castillo, Carlos Ferrone, Cristina R. Janseen, Quisette P. Balachandran, Vinod P. Sell, Naomi M. Drebin, Jeffrey A. Hank, Thomas Kingham, T. Peter D’Angelica, Michael I. Jarnagin, William R. Lillemoe, Keith D. Wei, Alice C. Qadan, Motaz